(19)
(11) EP 0 850 057 A1

(12)

(43) Date of publication:
01.07.1998 Bulletin 1998/27

(21) Application number: 96929780.0

(22) Date of filing: 30.08.1996
(51) International Patent Classification (IPC): 
A61K 31/ 00( . )
A61P 31/ 00( . )
A61P 35/ 00( . )
C07D 273/ 08( . )
C12N 1/ 20( . )
C12P 21/ 04( . )
A61K 31/ 395( . )
A61P 31/ 10( . )
C07D 273/ 00( . )
C07K 5/ 06( . )
C12P 21/ 02( . )
(86) International application number:
PCT/US1996/013855
(87) International publication number:
WO 1997/007798 (06.03.1997 Gazette 1997/11)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

(30) Priority: 30.08.1995 US 19950002935

(71) Applicants:
  • ELI LILLY AND COMPANY
    Indianapolis, Indiana 46285 (US)
  • UNIVERSITY OF HAWAII
    Honolulu, HI 96822 (US)
  • WAYNE STATE UNIVERSITY
    Detroit, MI 48202 (US)

(72) Inventors:
  • MOORE, Richard, E.
    Honolulu, HI 96816 (US)
  • PATEL, Vinod, F.
    Carmel, IN 46032 (US)
  • RAY, James, E.
    Indianapolis, IN 46268 (US)
  • TOTH, John, E.
    Indianapolis, IN 46278 (US)

(74) Representative: Hudson, Christopher Mark, et al 
Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor
Windlesham Surrey GU20 6PH
Windlesham Surrey GU20 6PH (GB)

   


(54) PHARMACEUTICAL COMPOUNDS